Skip to main content
Log in

Forum

  • Update
  • Published:
Pharmaceutical Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table I

Reference

Reference

  • Ragaz J, Spinelli JJ. Outcome of breast cancer therapies for adjuvant versus advanced disease: how much do they differ? Critical comments towards the present process of randomized trials as a pre-requisite for adjuvant therapy guidelines [abstract no. 14]. Breast Cancer Res Treat 2007 Dec; 106 Suppl. 1: 6 (plus oral presentation)

    Google Scholar 

References

Reference

  • The procedure for the ethical review of protocols for clinical research projects in the European Union. Int J Pharm Med 2007; 21 (1): 1–113

    Google Scholar 

Reference

References

  1. Tatsioni A, Bonitsis NG, Ioannidis JP. Persistence of contradicted claims in the literature. JAMA 2007 Dec 5; 298 (21): 2517–26

    Article  PubMed  CAS  Google Scholar 

  2. Avorn J. In defense of pharmacoepidemiology: embracing the Yin and Yang of drug research. N Engl J Med 2007 Nov 29; 357 (22): 2219–21

    Article  PubMed  CAS  Google Scholar 

References

  1. Yank V. Financial ties and concordance between results and conclusions in metaespecially analyses: retrospective cohort study. BMJ 2007 Dec 6; 335 (7631). Epub ahead of print

    Google Scholar 

  2. Epstein RA. Influence of pharmaceutical funding on the conclusions of meta-analyses: original data are sound, but conclusions should be interpreted with caution. BMJ 2007 Dec 8; 335 (7631): 1167

    Article  PubMed  Google Scholar 

Reference

  • Royal College of Physicians. Guidelines on the practice of ethics committees in medical research with human participants [online]. Available from URL: http://www.rcplondon.ac.uk/pubs [Accessed 2008 Jan 14]

Reference

  • Collier J. Parliamentary review asks NICE to do better still: out goes the arbitrary funding threshold: in come NICE directives. BMJ 2008 Jan 12; 336 (7635): 56–7

    Article  PubMed  Google Scholar 

Reference

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Forum. Pharm Med 22, 55–58 (2008). https://doi.org/10.1007/BF03256683

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03256683

Keywords

Navigation